Repatha (evolocumab ... The drug is given in the form of a subcutaneous injection, either 140 mg every two weeks or 420mg once a month. Before starting treatment, secondary causes of excess ...
and Sanofi/Regeneron’s Repatha (alirocumab) – but these require subcutaneous injection every two to four weeks. Sales of both the commercially available antibodies have failed to live up to ...